Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy of a personalized caplacizumab regimen based
on ADAMTS13 activity monitoring in adult acquired thrombotic thrombocytopenic purpura (aTTP):
This study is a phase II, prospective, multicenter non-inferiority single-arm study.